Daniel Lustberg, PhD, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Acid for Anxiety: Fast and Lasting Anxiolytic Effects of LSD

PT364 – Jamie Wheal – Burning Man, Psychedelic Maturity, and Radical...

atai Life Sciences Announces Positive Initial Results for Phase 1 Trial...

FILAMENT HEALTH TO HOST VIRTUAL INVESTOR UPDATE

Reunion Neuroscience CEO to Participate on Panel at 2022 Horizons Perspectives...

COMPASS Pathways Announces Phase 3 Pivotal Program Design for COMP360 in...

Clearmind Medicine Featured in “Psychedelics Tonight,” Streaming on ALTRD.TV

PsyBio Therapeutics Reaches Agreement to Conduct Initial Psilocybin Clinical Trial

PT363 – Reggie Harris – Cannabis and Psilocybin: The Complications of...

Optimi Health Announces Closing of Strategic Non-Brokered Private Placement

1...112113114...218 Page 113 of 218

EDITOR PICKS

After the Readout: How the Field Is Interpreting Compass’ Phase 3...

Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts

Compass Provides Fuller Phase 3 Picture, MADRS Curves, on Webcast

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin